Picture of Zydus Lifesciences logo

ZYDUSLIFE — Zydus Lifesciences News Story

0.000.00%
in flag iconLast trade - 00:00
HealthcareConservativeLarge CapHigh Flyer

Brief: Zydus Lifesciences Receives Tentative Approval From USFDA For Empagliflozin And Linagliptin Tablets

Nov 27 (Reuters) - Zydus Lifesciences Ltd ZYDU.NS:

ZYDUS LIFESCIENCES -  RECEIVES TENTATIVE APPROVAL FROM USFDA FOR EMPAGLIFLOZIN AND LINAGLIPTIN TABLETS

Source text: [ID:]

Further company coverage: ZYDU.NS

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Zydus Lifesciences

See all news